We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience. You can read our Cookie Policy here.

Advertisement
NuGEN Granted Patent for RNA Amplification Technology
News

NuGEN Granted Patent for RNA Amplification Technology

NuGEN Granted Patent for RNA Amplification Technology
News

NuGEN Granted Patent for RNA Amplification Technology

Read time:
 

Want a FREE PDF version of This News Story?

Complete the form below and we will email you a PDF version of "NuGEN Granted Patent for RNA Amplification Technology "

First Name*
Last Name*
Email Address*
Country*
Company Type*
Job Function*
Would you like to receive further email communication from Technology Networks?

Technology Networks Ltd. needs the contact information you provide to us to contact you about our products and services. You may unsubscribe from these communications at any time. For information on how to unsubscribe, as well as our privacy practices and commitment to protecting your privacy, check out our Privacy Policy

NuGEN Technologies, Inc. has announced that the United States Patent and Trademark Office issued U.S. Patent No. 6,946,251 entitled, "Methods and Compositions for Amplification of RNA Sequences."

This patent establishes protection around the company's innovative linear, isothermal RNA amplification technology which has widespread applications in life science research, therapeutic and diagnostics.

The patent covers methods, applications and kits, and provides protection for NuGEN's Ribo-SPIA™ methods and reagents that power NuGEN's Ovation™ family of products.

The Ovation™ System is designed to provide methods and reagents for both 3' based RNA amplification and whole transcriptome amplification.

Unlike the commonly used RNA amplification methods that are based on in vitro transcription, Ribo-SPIA™ is a single round amplification that is designed to provide efficient amplification to generate microgram amounts of cDNA products from minute (nanogram level and lower) amounts of total RNA.

NuGEN's isothermal nucleic acid amplification technologies are protected by a number of U.S. and foreign issued patents and patent applications.

Advertisement